Back to Infectious Disease
Infectious Diseasev2013Evidence-Based

Veterans Aging Cohort Study-Charlson Comorbidity Index (VACS-CCI)

Combines the Veterans Aging Cohort Study (VACS) Index with the Charlson Comorbidity Index to provide enhanced mortality risk prediction for patients with HIV. This integrated score incorporates HIV-specific biomarkers, general health indicators, and comprehensive comorbidity assessment to estimate 5-year all-cause mortality risk.

Clinical Input Parameters

years
Range: 18 — 100 years
cells/μL
Range: 0 — 2000 cells/μL
log10 copies/mL
Range: 0 — 7 log10 copies/mL
g/dL
Range: 5 — 20 g/dL
×10³/μL
Range: 10 — 1000 ×10³/μL
U/L
Range: 10 — 500 U/L
U/L
Range: 10 — 500 U/L
mg/dL
Range: 0.5 — 10 mg/dL
Clinical Assessment
Awaiting Parameters
vacs cci score
—percentage
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Veterans Aging Cohort Study-Charlson Comorbidity Index (VACS-CCI) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within infectious disease.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

VACS-CCI = [(Linear Predictor + 2.5390222) / 10.6663937] × 100, where Linear Predictor combines VACS Index components (age, CD4, HIV RNA, hemoglobin, FIB-4, eGFR, HCV) with Charlson Comorbidity Index weighted scores

Clinical Pearls & Practice Notes

  • Combines Veterans Aging Cohort Study Index with Charlson Comorbidity Index for enhanced mortality prediction
  • Incorporates both HIV-specific biomarkers and comprehensive comorbidity assessment
  • FIB-4 calculated as (Age × AST) / (Platelets × √ALT) for liver fibrosis assessment
  • eGFR calculated using CKD-EPI equation incorporating creatinine, age, sex, and race
  • Charlson comorbidities are weighted according to their impact on mortality risk
  • Score should be recalculated with updated laboratory values and clinical status
  • Developed and validated in HIV-infected veteran populations
  • Use in conjunction with clinical judgment for comprehensive patient assessment

Evidence & Literature Citations

  1. Justice AC, Lasky E, McGinnis KA, Skanderson M, Conigliaro J, Fultz SL, et al. Medical disease and alcohol use among veterans with human immunodeficiency infection: A comparison of disease measurement strategies. Med Care. 2006 Apr;44(4):S52-60. doi: 10.1097/01.mlr.0000208140.93199.44.
  2. McGinnis KA, Fultz SL, Skanderson M, Conigliaro J, Bryant K, Justice AC. Hepatocellular carcinoma and non-Hodgkin's lymphoma: the roles of HIV, hepatitis C infection, and alcohol abuse. J Clin Oncol. 2006 Nov 20;24(33):5005-9. doi: 10.1200/JCO.2006.05.7984.
  3. Tate JP, Justice AC, Hughes MD, Bonnet F, Reiss P, Mocroft A, et al. An internationally generalizable risk index for mortality after one year of antiretroviral therapy. AIDS. 2013 Feb 20;27(4):563-72. doi: 10.1097/QAD.0b013e32835c5b67.
  4. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83. doi: 10.1016/0021-9681(87)90171-8.

Score Interpretation Ranges

Low Risk0 – 25 pts

Low mortality risk

Moderate Risk26 – 50 pts

Moderate mortality risk

High Risk51 – 75 pts

High mortality risk

Very High Risk76 – 100 pts

Very high mortality risk

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.